These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7338557)

  • 61. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
    Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A double-blind crossover comparative study of the efficacy of single daily doses of conventional and slow-release metoprolol.
    Nievel JG; Harvard CW
    Curr Med Res Opin; 1981; 7(8):503-15. PubMed ID: 7030636
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metoprolol succinate combination in the treatment of hypertension.
    Papadopoulos DP; Papademetriou V
    Angiology; 2009; 60(5):608-13. PubMed ID: 19033265
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.
    Oosterhuis B; Jonkman JH; Kerkhof FA
    Eur J Clin Pharmacol; 1988; 33 Suppl():S15-8. PubMed ID: 3371389
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians.
    Salako LA; Falase AO; Aderounmu AF; Walker O
    Afr J Med Med Sci; 1990 Mar; 19(1):57-61. PubMed ID: 2109522
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man.
    Rönn O; Graffner C; Johnsson G; Jordö L; Lundborg P; Wikstrand J
    Eur J Clin Pharmacol; 1979 Feb; 15(1):9-13. PubMed ID: 33811
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
    Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
    Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
    Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
    N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bioavailability in man of atenolol and chlorthalidone from a combination formulation.
    McAinsh J; Holmes BH; Fitzsimons TJ; Young J
    Biopharm Drug Dispos; 1986; 7(3):223-31. PubMed ID: 3730522
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug therapy: metoprolol.
    Koch-Weser J
    N Engl J Med; 1979 Sep; 301(13):698-703. PubMed ID: 225665
    [No Abstract]   [Full Text] [Related]  

  • 72. Effects of two doses of the fixed-combination chlorthalidone and slow-release metoprolol on blood pressure at rest and during exercise: a multicenter study.
    Caponnetto S; Alberti D; Bafico GL; Bertulla A; Camerieri A; Francucci BM; Gatto E; Gentile A; Livi S; Mereto PE
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):574-9. PubMed ID: 3781678
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of age on the pharmacokinetics of metoprolol and its metabolites.
    Quarterman CP; Kendall MJ; Jack DB
    Br J Clin Pharmacol; 1981 Mar; 11(3):287-94. PubMed ID: 7213530
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ventilatory effects of ordinary and slow-release tablets of metoprolol in asthmatic patients.
    van den Bergh JH; van Herwaarden CL
    Eur J Respir Dis; 1981 Jun; 62(3):168-72. PubMed ID: 7308331
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of pindolol and metoprolol on plasma lipids and lipoproteins.
    Pasotti C; Capra A; Fiorella G; Vibelli C; Chierichetti SM
    Br J Clin Pharmacol; 1982; 13(Suppl 2):435S-439S. PubMed ID: 7104157
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites.
    Hoffmann KJ; Regårdh CG; Aurell M; Ervik M; Jordö L
    Clin Pharmacokinet; 1980; 5(2):181-91. PubMed ID: 7363533
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.
    Velasco M; Guevara J; Morillo J; Ramírez A; Urbina-Quintana A; Hernández-Pieretti O
    Br J Clin Pharmacol; 1980 May; 9(5):499-504. PubMed ID: 6994790
    [No Abstract]   [Full Text] [Related]  

  • 78. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
    Teeuw AH; Leenen FH; Geyskes GG; Boer P
    Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
    Regårdh CG; Jordö L; Ervik M; Lundborg P; Olsson R; Rönn O
    Clin Pharmacokinet; 1981; 6(5):375-88. PubMed ID: 7333059
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol.
    Jack DB; Kendall MJ; Dean S; Laugher SJ; Zaman R; Tenneson ME
    Biopharm Drug Dispos; 1982; 3(1):47-54. PubMed ID: 6123352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.